SMTL ID : 6jux.1

Crystal structure of human ALK2 kinase domain with R206H mutation in complex with RK-71807

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.75 Å

Oligo State

monomer

Ligands

1 x C9U: 4-(1-ethyl-3-pyridin-3-yl-pyrazol-4-yl)-~{N}-(4-piperazin-1-ylphenyl)pyrimidin-2-amine(Non-covalent)

C9U.1: 17 residues within 4Å: Chain A: V.14, Y.19, V.22, A.33, K.35, L.63, L.81, T.83, H.84, Y.85, H.86, E.87, M.88, G.89, D.93, K.140, L.143 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.14, A:Y.19, A:V.22, A:V.22, A:K.35, A:L.63, A:T.83, A:L.143 Hydrogen bonds: A:H.86, A:H.86, A:D.93 Water bridges: A:D.154, A:D.154

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 5 residues within 4Å: Chain A: K.140, R.180, N.237, D.238, P.239 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:D.238, A:D.238, A:D.238 Salt bridges: A:K.140, A:R.180 SO4.3: 3 residues within 4Å: Chain A: H.86, K.145, K.146 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:K.146 Water bridges: A:E.87, A:N.147 Salt bridges: A:H.86, A:K.146

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sato, T. et al., Structural Basis of Activin Receptor-Like Kinase 2 (R206H) Inhibition by Bis-heteroaryl Pyrazole-Based Inhibitors for the Treatment of Fibrodysplasia Ossificans Progressiva Identified by the Integration of Ligand-Based and Structure-Based Drug Design Approaches. Acs Omega (2020)

Release Date

2020-04-15

Peptides

Activin receptor type-1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Activin receptor type-1